What Is Dementia?

Dementia is a clinical syndrome characterized by progressive deterioration in cognitive function, including memory, reasoning, language, and executive function, severe enough to impair daily activities. It is not a single disease but an umbrella term covering many neurodegenerative and vascular conditions that share the common feature of declining brain function over time. Alzheimer's disease accounts for approximately 60 to 70 percent of dementia cases worldwide; other common forms include vascular dementia, Lewy body dementia, and frontotemporal dementia. The World Health Organization estimates that more than 55 million people globally live with dementia, making it a major focus of biomedical research, clinical care, and health technology development.

Dementia research draws from neuroscience, neuropathology, geriatric medicine, and increasingly from electrical and computer engineering as sensor technology, machine learning, and neuroimaging have become central tools in diagnosis and monitoring.

Pathology and Biomarkers

At the biological level, dementia involves the accumulation of abnormal proteins in brain tissue, loss of synaptic connections, and atrophy of cortical regions. Alzheimer's disease is characterized by amyloid-beta plaques and neurofibrillary tangles composed of hyperphosphorylated tau protein. Vascular dementia arises from reduced cerebrovascular blood flow, often following strokes or chronic small vessel disease. Identifying reliable biomarkers for early-stage disease has been a central research priority, with cerebrospinal fluid protein assays, positron emission tomography (PET) imaging, and blood-based plasma biomarkers among the established approaches. Research published in npj Digital Medicine surveys an expanding range of digital biomarkers derived from wearable sensors, speech analysis, and eye-tracking as complements to conventional biological markers.

Neuroimaging and Computational Diagnosis

Structural and functional neuroimaging plays an important role in characterizing dementia subtypes and tracking disease progression. Magnetic resonance imaging (MRI) and PET scans reveal patterns of cortical atrophy and metabolic decline characteristic of specific dementias. Machine learning algorithms applied to neuroimaging data have demonstrated the ability to distinguish Alzheimer's disease from healthy aging and from other neurodegenerative syndromes. An adaptive ensemble manifold learning approach evaluated against the Alzheimer's Disease Neuroimaging Initiative database showed that combining multiple neuroimaging modalities substantially improves diagnostic accuracy over single-modality approaches. Deep learning models have also been applied to MRI time series to predict conversion from mild cognitive impairment to full Alzheimer's disease, enabling earlier clinical intervention.

Assistive and Monitoring Technologies

Engineering and computer science contribute substantially to dementia care through assistive technologies and remote monitoring systems. Wearable devices track activity patterns, sleep quality, and physiological signals, while smart home sensor arrays detect changes in daily living routines that may signal cognitive decline. Natural language processing systems analyze speech samples for markers of memory impairment, word-finding difficulty, and semantic content loss. Internet of Things-based monitoring platforms combine environmental and physiological data streams to assess patient wellbeing and alert caregivers to changes in behavioral patterns. IEEE publications in biomedical engineering, including work reviewed in IEEE Reviews in Biomedical Engineering, examine how these systems can be integrated into dementia care frameworks while addressing privacy, consent, and interoperability challenges.

Applications

Dementia research and technology have applications across several fields, including:

• Clinical neurology and geriatric medicine, where biomarkers and neuroimaging guide diagnosis and treatment selection
• Wearable health monitoring, where continuous sensing supports remote assessment of cognitive status
• Caregiver support systems, where automated alerts and behavioral dashboards reduce monitoring burden
• Drug discovery, where computational models of disease progression inform clinical trial design
• Smart home technology, where ambient sensors enable aging-in-place for individuals with early-stage dementia